Skip to main content
LSTA logo

Lisata Therapeutics, Inc.

LSTANASDAQ

$1.00Today:- (-)1Y −57.23%

As of Oct 23, 2026 close

Market cap
$9.07M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.96$5.07
Volume (live)
-
Avg. volume (3M)
215.99K

Lisata Therapeutics (LSTA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Lisata Therapeutics reported total assets of $17.74M and total liabilities of $3.14M. Shareholders' equity was $14.86M, down 49.3% from $29.32M a year earlier. Total debt stood at $0.00 against $15.96M in cash and short-term investments, a net cash position of $15.96M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Lisata Therapeutics Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Lisata Therapeutics, Inc. (LSTA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents15.9616.2122.5932.1524.6516.5114.0310.3029.16
Short-Term Investments0.0015.0427.9437.0770.3218.0611.1332.7525.92
Cash & Short-Term Investments15.9631.2550.5469.2394.9734.5725.1643.0555.08
Accounts Receivable0.700.900.000.700.000.000.000.000.23
Inventory0.000.000.000.000.000.000.000.005.00
Other Current Assets1.752.433.392.651.210.760.821.056.08
Total Current Assets17.7034.5853.9271.8896.1835.3325.9744.1161.11
Non-Current Assets
Property, Plant & Equipment (Net)0.020.070.180.300.060.630.100.170.26
Intangible Assets0.000.190.260.330.000.000.000.000.00
Other Non-Current Assets0.020.160.330.530.760.041.080.311.43
Total Non-Current Assets0.040.420.771.160.830.671.180.472.27
Total Assets17.7435.0054.6973.0397.0136.0027.1544.5863.38
Current Liabilities
Accounts Payable1.021.282.422.661.931.021.490.761.34
Short-Term Debt0.000.140.170.180.230.370.350.000.16
Accrued Liabilities2.054.334.003.732.592.12---
Other Current Liabilities2.054.194.003.552.362.124.134.867.81
Total Current Liabilities3.075.616.596.384.523.515.985.629.31
Non-Current Liabilities
Long-Term Debt0.000.000.000.310.490.250.620.000.00
Other Non-Current Liabilities0.070.070.210.330.490.000.001.513.87
Total Non-Current Liabilities0.070.070.210.330.490.250.621.513.87
Total Liabilities3.145.696.806.715.013.766.607.1313.19
Stockholders' Equity
Common Stock0.010.010.010.010.000.020.010.010.01
Retained Earnings-564.65-548.07-528.08-507.24-453.02-425.55-417.40-397.98-381.81
Accumulated Other Comprehensive Income-0.04-0.08-0.04-0.03-0.07-0.010.00-0.03-0.03
Treasury Stock0.710.710.710.710.71----
Additional Paid-in Capital580.24577.71576.97574.55546.04458.04438.20435.73432.36
Minority Interest-0.25-0.25-0.25-0.25-0.25-0.25-0.26-0.27-0.32
Shares Outstanding8.838.418.157.903.99----
Total Stockholders' Equity14.8629.3248.1566.3292.0032.2420.8237.7350.51
Total Liabilities & Equity17.7435.0054.6973.0397.0136.0027.1544.5863.38

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Lisata Therapeutics Balance Sheet

How much debt does Lisata Therapeutics have?

Lisata Therapeutics had total debt of $0.00 as of Dec 31, 2025, against $15.96M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $137.00K a year earlier.

What are Lisata Therapeutics's total assets?

Lisata Therapeutics reported total assets of $17.74M as of Dec 31, 2025, down 49.3% from $35.00M a year earlier. Total liabilities were $3.14M.

What is Lisata Therapeutics's shareholders' equity?

Lisata Therapeutics's shareholders' equity was $14.86M as of Dec 31, 2025, or about $1.68 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition